CONMED Total Assets 2010-2022 | CNMD

CONMED total assets from 2010 to 2022. Total assets can be defined as the sum of all assets on a company's balance sheet.
CONMED Annual Total Assets
(Millions of US $)
2021 $1,766
2020 $1,752
2019 $1,775
2018 $1,369
2017 $1,358
2016 $1,329
2015 $1,102
2014 $1,098
2013 $1,091
2012 $1,079
2011 $936
2010 $986
2009 $958
CONMED Quarterly Total Assets
(Millions of US $)
2022-03-31 $1,786
2021-12-31 $1,766
2021-09-30 $1,754
2021-06-30 $1,762
2021-03-31 $1,747
2020-12-31 $1,752
2020-09-30 $1,743
2020-06-30 $1,724
2020-03-31 $1,751
2019-12-31 $1,775
2019-09-30 $1,758
2019-06-30 $1,759
2019-03-31 $1,761
2018-12-31 $1,369
2018-09-30 $1,363
2018-06-30 $1,364
2018-03-31 $1,350
2017-12-31 $1,358
2017-09-30 $1,361
2017-06-30 $1,335
2017-03-31 $1,328
2016-12-31 $1,329
2016-09-30 $1,331
2016-06-30 $1,339
2016-03-31 $1,343
2015-12-31 $1,102
2015-09-30 $1,094
2015-06-30 $1,089
2015-03-31 $1,088
2014-12-31 $1,098
2014-09-30 $1,110
2014-06-30 $1,097
2014-03-31 $1,083
2013-12-31 $1,091
2013-09-30 $1,084
2013-06-30 $1,083
2013-03-31 $1,083
2012-12-31 $1,079
2012-09-30 $1,089
2012-06-30 $1,061
2012-03-31 $1,077
2011-12-31 $936
2011-09-30 $999
2011-06-30 $1,000
2011-03-31 $992
2010-12-31 $986
2010-09-30 $1,003
2010-06-30 $987
2010-03-31 $992
2009-12-31 $958
2009-09-30 $951
2009-06-30 $931
2009-03-31 $928
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.875B $1.011B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $71.295B 20.58
McKesson (MCK) United States $46.842B 13.77
AmerisourceBergen (ABC) United States $31.256B 14.42
West Pharmaceutical Services (WST) United States $22.580B 34.40
Laboratory Of America Holdings (LH) United States $22.369B 9.34
Cooper (COO) United States $15.890B 24.45
Cardinal Health (CAH) United States $14.945B 11.48
Invacare (IVC) United States $0.055B 0.00